Now showing items 1-10 of 3

    Antineoplastic Combined Chemotherapy Protocols (3)
    Bevacizumab (3)
    Humans (3)
    Adenocarcinoma (2)
    Aged (2)
    Female (2)
    Male (2)
    Middle Aged (2)
    Adult (1)
    Afatinib (1)